IF by specialty › Oncology
Cancer Discovery — Impact Factor
The 2025 Impact Factor of Cancer Discovery is 29.5 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 29.5 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- AACR
- Open access
- subscription or hybrid
- Abbreviations
- Cancer Discov
- IF source
- bioxbio.com
Position within the field
Ranked 9 of the 42 journals in Oncology on this site (top 25%).
Oncology journals with a similar Impact Factor
- Molecular Cancer IF 42.2
- Lancet Oncology IF 33.7
- Nature Cancer IF 28.0
- JAMA Oncology IF 23.9
- Journal of Thoracic Oncology IF 23.3
- Cancer Research IF 22.6
About this value
Cancer Discovery is abbreviated Cancer Discov. The Journal Impact Factor of Cancer Discovery (JCR 2025, released June 2026) is 29.5. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.